Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Lycopene In Preventing of Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Brachytherapy in Treating Patients With Recurrent Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1